Ge Zhou

2.5k total citations
32 papers, 1.8k citations indexed

About

Ge Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ge Zhou has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Ge Zhou's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related Molecular Pathways (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Ge Zhou is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related Molecular Pathways (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Ge Zhou collaborates with scholars based in United States, China and Russia. Ge Zhou's co-authors include Sophia Y. Tsai, Ming‐Jer Tsai, Fred A. Pereira, Yufan Qiu, Yingming Zhao, John W. Gillespie, Michael R. Emmert‐Buck, Emanuel F. Petricoin, Michael J. Flaig and Yi Gong and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Molecular and Cellular Biology.

In The Last Decade

Ge Zhou

31 papers receiving 1.8k citations

Peers

Ge Zhou

ONCOL

SPECT

GENET

Rosaria Orlandi Italy

Graham Steers United Kingdom

Troels Zakarias Kristiansen United States

Christian Melle Germany

Matthew P. Stokes United States

Koen Kas Belgium

Dean J. Bacich United States

Emmanuelle Liaudet‐Coopman France

Stephen O. Brennan New Zealand

Philipp F. Lange Canada

Rosaria Orlandi Italy

Ge Zhou

1.5k ×1.3

599 ×1.6

ONCOL

146 ×0.5

SPECT

385 ×1.3

180 ×0.7

GENET

Citations per year, relative to Ge Zhou Ge Zhou (= 1×) peers Rosaria Orlandi

Countries citing papers authored by Ge Zhou

Since Specialization

Citations

This map shows the geographic impact of Ge Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Zhou more than expected).

Fields of papers citing papers by Ge Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Zhou. The network helps show where Ge Zhou may publish in the future.

Co-authorship network of co-authors of Ge Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Zhou. A scholar is included among the top collaborators of Ge Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Zhou. Ge Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Ge, et al.. (2025). Neuro-Ophthalmic Presentations of Polycythemia. Journal of Neuro-Ophthalmology. 45(4). 473–482.

Sun, Jinlong, et al.. (2023). Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy. 2(1). 6 indexed citations

Zhang, Yaxing, Ge Zhou, Zifeng Chen, et al.. (2020). Si‐Wu‐Tang Alleviates Nonalcoholic Fatty Liver Disease via Blocking TLR4‐JNK and Caspase‐8‐GSDMD Signaling Pathways. Evidence-based Complementary and Alternative Medicine. 2020(1). 8786424–8786424. 14 indexed citations

Chen, Yan, et al.. (2020). Constructing the Logical Regression Model to Predict the Target of Jianpi Jiedu Decoction in the Treatment of Hepatocellular Carcinoma. Evidence-based Complementary and Alternative Medicine. 2020(1). 8859558–8859558. 2 indexed citations

Wang, Jianglin, Wenjun Yin, Lingyun Zhou, et al.. (2019). Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis. Clinical Rheumatology. 39(3). 769–778. 43 indexed citations

Schiff, Bradley A., Samar A. Jasser, Maher N. Younes, et al.. (2019). Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clinical Cancer Research. 25(15). 4862–4862. 3 indexed citations

Ma, Hailong, Shufang Jin, Wenyi Yang, et al.. (2018). Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma. British Journal of Cancer. 118(4). 509–521. 32 indexed citations

Ma, Hailong, Shufang Jin, Wen‐Yi Yang, et al.. (2017). Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma. Journal of Cancer. 8(12). 2384–2393. 22 indexed citations

Tanaka, Noriaki, Mei Zhao, Lin Tang, et al.. (2017). Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Oncogene. 37(10). 1279–1292. 41 indexed citations

10.

Tanaka, Noriaki, Ameeta A. Patel, Jiping Wang, et al.. (2015). Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Clinical Cancer Research. 21(21). 4831–4844. 46 indexed citations

11.

Kupferman, Michael E., Tilahun Jiffar, Adel K. El‐Naggar, et al.. (2010). TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene. 29(14). 2047–2059. 170 indexed citations

12.

Sano, Daisuke, Sung Weon Choi, Zvonimir L. Milas, et al.. (2009). The Effect of Combination Anti–Endothelial Growth Factor Receptor and Anti–Vascular Endothelial Growth Factor Receptor 2 Targeted Therapy on Lymph Node Metastasis. Archives of Otolaryngology - Head and Neck Surgery. 135(4). 411–411. 19 indexed citations

13.

Zhou, Ge, Meina Zhao, S Jasser, et al.. (2008). Reciprocal negative regulation between S100A7/psoriasin and β-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene. 27(25). 3527–3538. 49 indexed citations

14.

Xie, Bo, Ge Zhou, Ellen Shapiro, et al.. (2006). Distinct Glycan Structures of Uroplakins Ia and Ib. Journal of Biological Chemistry. 281(21). 14644–14653. 100 indexed citations

15.

Zhou, Ge, Hongmei Li, Yi Gong, et al.. (2005). Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. PROTEOMICS. 5(14). 3814–3821. 28 indexed citations

16.

Zhang, Wei, Ge Zhou, Yingxin Zhao, Michael A. White, & Yingming Zhao. (2003). Affinity enrichment of plasma membrane for proteomics analysis. Electrophoresis. 24(16). 2855–2863. 75 indexed citations

17.

Zhou, Ge, Hongmei Li, Dianne L. DeCamp, et al.. (2002). 2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers. Molecular & Cellular Proteomics. 1(2). 117–123. 306 indexed citations

18.

He, Jin, Ge Zhou, Kang–Da Liu, & Xinyu Qin. (2002). Construction and Preliminary Screening of a Human Phage Single-Chain Antibody Library Associated with Gastric Cancer. Journal of Surgical Research. 102(2). 150–155. 4 indexed citations

19.

Pereira, Fred A., Yufan Qiu, Ge Zhou, Ming‐Jer Tsai, & Sophia Y. Tsai. (1999). The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes & Development. 13(8). 1037–1049. 419 indexed citations

20.

Zhou, Ge, et al.. (1997). Reconstruction and expression of chimeric anti-HBx antibody inEscherichia coli. Journal of Cancer Research and Clinical Oncology. 123(6). 325–330. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact